Announcement, Press Release | 10.03.24 PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release | 07.31.24 Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release | 07.18.24 Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release | 06.27.24 The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators
Press Release | 04.30.24 BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Announcement, Press Release | 12.13.23 Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium
Announcement, Our Impact, Press Release | 06.27.23 Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Announcement, Partner Highlight, Press Release | 08.24.22 LumaBridge and the Parker Institute for Cancer Immunotherapy Form Strategic Alliance to Speed Access to Clinical Trial Services for Partners
Announcement, Our Impact, Press Release | 07.27.22 Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers
Announcement, Partner Highlight, Press Release | 06.08.22 The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
Announcement, Press Release | 06.03.22 Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer
Announcement, Press Release | 11.03.21 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial